Oryzon Genomics SA
MAD:ORY

Watchlist Manager
Oryzon Genomics SA Logo
Oryzon Genomics SA
MAD:ORY
Watchlist
Price: 1.654 EUR 0.98% Market Closed
Market Cap: 105.5m EUR
Have any thoughts about
Oryzon Genomics SA?
Write Note

Oryzon Genomics SA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Oryzon Genomics SA
Operating Income Peer Comparison

Comparables:
GRF
PHM
BST

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Oryzon Genomics SA
MAD:ORY
Operating Income
-€4.5m
CAGR 3-Years
-2%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Grifols SA
MAD:GRF
Operating Income
€735.7m
CAGR 3-Years
-9%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Pharma Mar SA
MAD:PHM
Operating Income
-€9.8m
CAGR 3-Years
N/A
CAGR 5-Years
20%
CAGR 10-Years
N/A
Biotechnology Assets SA
MAD:BST
Operating Income
€3.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Oryzon Genomics SA's Operating Income?
Operating Income
-4.5m EUR

Based on the financial report for Dec 31, 2023, Oryzon Genomics SA's Operating Income amounts to -4.5m EUR.

What is Oryzon Genomics SA's Operating Income growth rate?
Operating Income CAGR 5Y
-9%

Over the last year, the Operating Income growth was 17%. The average annual Operating Income growth rates for Oryzon Genomics SA have been -2% over the past three years , -9% over the past five years .

Back to Top